These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1284 related items for PubMed ID: 19344721

  • 1. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
    Villanueva C, Aracil C, Colomo A, Hernández-Gea V, López-Balaguer JM, Alvarez-Urturi C, Torras X, Balanzó J, Guarner C.
    Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
    [Abstract] [Full Text] [Related]

  • 2. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS, Bosch J, Portal Hypertension Collaborative Group.
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension.
    La Mura V, Abraldes JG, Raffa S, Retto O, Berzigotti A, García-Pagán JC, Bosch J.
    J Hepatol; 2009 Aug; 51(2):279-87. PubMed ID: 19501930
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis.
    Turnes J, Garcia-Pagan JC, Abraldes JG, Hernandez-Guerra M, Dell'Era A, Bosch J.
    Am J Gastroenterol; 2006 Mar; 101(3):506-12. PubMed ID: 16542287
    [Abstract] [Full Text] [Related]

  • 5. Preventing first variceal hemorrhage in cirrhosis.
    Albillos A.
    J Clin Gastroenterol; 2007 Mar; 41 Suppl 3():S305-11. PubMed ID: 17975481
    [Abstract] [Full Text] [Related]

  • 6. Value of the hepatic venous pressure gradient to monitor drug therapy for portal hypertension: a meta-analysis.
    Albillos A, Bañares R, González M, Ripoll C, Gonzalez R, Catalina MV, Molinero LM.
    Am J Gastroenterol; 2007 May; 102(5):1116-26. PubMed ID: 17391317
    [Abstract] [Full Text] [Related]

  • 7. Development of ascites in compensated cirrhosis with severe portal hypertension treated with β-blockers.
    Hernández-Gea V, Aracil C, Colomo A, Garupera I, Poca M, Torras X, Miñana J, Guarner C, Villanueva C.
    Am J Gastroenterol; 2012 Mar; 107(3):418-27. PubMed ID: 22334252
    [Abstract] [Full Text] [Related]

  • 8. Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension.
    Escorsell A, Bordas JM, Castañeda B, Llach J, García-Pagán JC, Rodés J, Bosch J.
    Hepatology; 2000 May; 31(5):1061-7. PubMed ID: 10796880
    [Abstract] [Full Text] [Related]

  • 9. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.
    Reiberger T, Ulbrich G, Ferlitsch A, Payer BA, Schwabl P, Pinter M, Heinisch BB, Trauner M, Kramer L, Peck-Radosavljevic M, Vienna Hepatic Hemodynamic Lab.
    Gut; 2013 Nov; 62(11):1634-41. PubMed ID: 23250049
    [Abstract] [Full Text] [Related]

  • 10. Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary study.
    Abecasis R, Kravetz D, Fassio E, Ameigeiras B, Garcia D, Isla R, Landeira G, Dominguez N, Romero G, Argonz J, Terg R.
    Hepatology; 2003 Feb; 37(2):359-65. PubMed ID: 12540786
    [Abstract] [Full Text] [Related]

  • 11. Acute and chronic hemodynamic changes after propranolol in patients with cirrhosis under primary and secondary prophylaxis of variceal bleeding: a pilot study.
    de-Madaria E, Palazón JM, Hernández FT, Sánchez-Paya J, Zapater P, Irurzun J, de España F, Pascual S, Such J, Sempere L, Carnicer F, García-Herola A, Valverde J, Pérez-Mateo M.
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):507-12. PubMed ID: 20150817
    [Abstract] [Full Text] [Related]

  • 12. Hemodynamic response-guided therapy for prevention of variceal rebleeding: an uncontrolled pilot study.
    González A, Augustin S, Pérez M, Dot J, Saperas E, Tomasello A, Segarra A, Armengol JR, Malagelada JR, Esteban R, Guardia J, Genescà J.
    Hepatology; 2006 Oct; 44(4):806-12. PubMed ID: 17006916
    [Abstract] [Full Text] [Related]

  • 13. Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial.
    Mishra SR, Chander Sharma B, Kumar A, Sarin SK.
    Gut; 2010 Jun; 59(6):729-35. PubMed ID: 20551457
    [Abstract] [Full Text] [Related]

  • 14. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis.
    Merkel C, Bolognesi M, Sacerdoti D, Bombonato G, Bellini B, Bighin R, Gatta A.
    Hepatology; 2000 Nov; 32(5):930-4. PubMed ID: 11050041
    [Abstract] [Full Text] [Related]

  • 15. Beta-blockers for prophylaxis of bleeding from esophageal varices in cirrhotic portal hypertension. Review of the literature.
    Zoller WG, Gross M.
    Eur J Med Res; 1996 Jun 25; 1(9):407-16. PubMed ID: 9353240
    [Abstract] [Full Text] [Related]

  • 16. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria.
    Merkel C, Bolognesi M, Berzigotti A, Amodio P, Cavasin L, Casarotto IM, Zoli M, Gatta A.
    J Hepatol; 2010 Jan 25; 52(1):45-53. PubMed ID: 19914730
    [Abstract] [Full Text] [Related]

  • 17. Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis.
    Feu F, Bordas JM, Luca A, García-Pagán JC, Escorsell A, Bosch J, Rodés J.
    Hepatology; 1993 Nov 25; 18(5):1082-9. PubMed ID: 8225212
    [Abstract] [Full Text] [Related]

  • 18. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study.
    La Mura V, Abraldes JG, Berzigotti A, Erice E, Flores-Arroyo A, García-Pagán JC, Bosch J.
    Hepatology; 2010 Jun 25; 51(6):2108-16. PubMed ID: 20512998
    [Abstract] [Full Text] [Related]

  • 19. Pharmacologic prevention of variceal bleeding and rebleeding.
    Baiges A, Hernández-Gea V, Bosch J.
    Hepatol Int; 2018 Feb 25; 12(Suppl 1):68-80. PubMed ID: 29210030
    [Abstract] [Full Text] [Related]

  • 20. Early identification of haemodynamic response to pharmacotherapy is essential for primary prophylaxis of variceal bleeding in patients with 'high-risk' varices.
    Sharma P, Kumar A, Sharma BC, Sarin SK.
    Aliment Pharmacol Ther; 2009 Jul 25; 30(1):48-60. PubMed ID: 19392862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 65.